Premium
A single center evaluation of cost savings related to treatment‐free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco‐economy larger study
Author(s) -
Etienne Gabriel,
Dulucq Stéphanie,
Faberes Carole,
Bijou Fontanet,
Schmitt Anna,
Klein Emilie,
Fort MariePierre,
Durrieu Françoise,
Toulza Emilie,
Mahon FrançoisXavier
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16511
Subject(s) - discontinuation , medicine , myeloid leukemia , cohort , adverse effect , nilotinib , tyrosine kinase inhibitor , imatinib , pediatrics , cancer